|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.75 TWD | +0.15% |
|
+11.02% | +73.52% |
| Apr. 19 | 3D Global Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | 3D Global Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
3D Global Biotech Inc. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 6.37 million compared to TWD 7.57 million a year ago. Net loss was TWD 32.78 million compared to TWD 25.74 million a year ago.
Basic loss per share from continuing operations was TWD 0.61 compared to TWD 0.48 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +73.52% | 68.06M | |
| -3.77% | 184B | |
| -1.77% | 107B | |
| -1.43% | 69.44B | |
| +2.06% | 50.37B | |
| +9.43% | 44.82B | |
| +3.40% | 41.53B | |
| +3.04% | 26.73B | |
| +4.64% | 26.84B | |
| +15.23% | 25.71B |
3D GLOBAL BIOTECH INC. 
